Preventing acute leukemia relapse after allogeneic transplants: how to move forward?
- PMID: 23290793
- DOI: 10.1016/j.bbmt.2012.11.009
Preventing acute leukemia relapse after allogeneic transplants: how to move forward?
Comment on
-
High alloreactivity of low-dose prophylactic donor lymphocyte infusion in patients with acute leukemia undergoing allogeneic hematopoietic cell transplantation with an alemtuzumab-containing conditioning regimen.Biol Blood Marrow Transplant. 2013 Jan;19(1):75-81. doi: 10.1016/j.bbmt.2012.07.021. Epub 2012 Aug 4. Biol Blood Marrow Transplant. 2013. PMID: 22871557 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical